4//SEC Filing
Radovich Peter 4
Accession 0001415889-25-001952
CIK 0001759425other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:51 PM ET
Size
10.7 KB
Accession
0001415889-25-001952
Insider Transaction Report
Form 4
Radovich Peter
PRESIDENT AND COO
Transactions
- Award
Stock Option (right to buy)
2025-01-21+50,000→ 50,000 totalExercise: $47.98Exp: 2035-01-20→ Common Stock (50,000 underlying) - Award
Restricted Stock Units
2025-01-21+12,500→ 12,500 total→ Common Stock (12,500 underlying) - Award
Performance Restricted Stock Units
2025-01-21+21,660→ 21,660 total→ Common Stock (21,660 underlying)
Footnotes (4)
- [F1]1/4th of the shares vest one year after January 21, 2025 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.
- [F4]On January 31, 2023, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 21, 2025, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026.
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
Related Parties
1- filerCIK 0001650131
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 5:51 PM ET
- Size
- 10.7 KB